Division of Molecular/Experimental Radiology, Department of Radiology, Rheinische Friedrich-Wilhelms-University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
EPMA J. 2010 Mar;1(1):13-8. doi: 10.1007/s13167-010-0006-5. Epub 2010 Mar 23.
Diabetes mellitus (DM) is a lifelong progressive disease. Currently there are more than 285 million DM-affected people worldwide. Globally the prevalence of diabetes continues to rise and is more pronounced in countries with large populations such as China, India and USA. Driving forces behind the epidemic are obesity, aging of the population and longer life expency. Prospective, the majority of diabetic population will be in their six to eight decades of life with the implication of more females than males. Severe micro- and macrovascular complications associated with diabetes lead to a highly increased morbidity and mortality. Therefore, DM is projected to be one of the leading health problems of 21st centuary. Urgent measures are required to reduce the diabetic burden. Thus advanced predictive diagnostic tools and personalized treatment strategies in (pre)diabetic care are critical and should exert beneficial impact on public health.
糖尿病（DM）是一种终身进展性疾病。目前全球有超过 2.85 亿名 DM 患者。全球范围内，糖尿病的患病率持续上升，在人口众多的国家如中国、印度和美国更为明显。肥胖、人口老龄化和预期寿命延长是这一流行趋势的主要驱动力。预计未来大多数糖尿病患者将处于六到八十岁的年龄段，女性人数将多于男性。与糖尿病相关的严重微血管和大血管并发症导致发病率和死亡率显著增加。因此，DM 预计将成为 21 世纪主要的健康问题之一。需要采取紧急措施来减轻糖尿病负担。因此，在（糖尿病前期）糖尿病护理中，先进的预测性诊断工具和个性化治疗策略至关重要，应该对公众健康产生有益的影响。
